Overexpression of IFITM1 Has Clinicopathologic Effects on Gastric Cancer and Is Regulated by an Epigenetic Mechanism
The American Journal of Pathology, 06/29/2012
Lee J et al. – The authors demonstrated gastric cancer–specific overexpression of IFITM1 regulated by promoter methylation and the role of IFITM1 in cancer prognosis.



